Report Detail

Pharma & Healthcare Global (United States, European Union and China) Smoking Cessation Drugs Market Research Report 2019-2025

  • RnM3687053
  • |
  • 21 August, 2019
  • |
  • Global
  • |
  • 119 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Smoking cessation (also known as quitting smoking or simply quitting) is the process of discontinuing tobacco smoking. Tobacco smoke contains nicotine, which is addictive. Nicotine withdrawal makes the process of quitting often very prolonged and difficult.
Americas accounted for almost 42% of the market share and is expected to grow at a CAGR of around 13% during the forecast period. The decline in smoker’s population due to rising health consciousness and the increased preference for the use of e-cigarettes and nicotine replacement therapy products are the primary drivers for the market growth in this region.
In 2019, the market size of Smoking Cessation Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Smoking Cessation Drugs.

This report studies the global market size of Smoking Cessation Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Smoking Cessation Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
GSK
Pfizer
Kimree Technology
Johnson & Johnson
Novartis
Dr. Reddy's Laboratories
The Harvard Drug Group
Perrigo Company
Fontem Ventures
Smoke Away

Market Segment by Product Type
NRTs Products
Nicotine-Free Products

Market Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Smoking Cessation Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Smoking Cessation Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Smoking Cessation Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Smoking Cessation Drugs Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 NRTs Products
      • 1.3.3 Nicotine-Free Products
    • 1.4 Market Segment by Application
      • 1.4.1 Global Smoking Cessation Drugs Market Share by Application (2019-2025)
      • 1.4.2 Hospital Pharmacies
      • 1.4.3 Retail Pharmacies
      • 1.4.4 Online Pharmacies
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Smoking Cessation Drugs Market Size
      • 2.1.1 Global Smoking Cessation Drugs Revenue 2014-2025
      • 2.1.2 Global Smoking Cessation Drugs Sales 2014-2025
    • 2.2 Smoking Cessation Drugs Growth Rate by Regions
      • 2.2.1 Global Smoking Cessation Drugs Sales by Regions 2014-2019
      • 2.2.2 Global Smoking Cessation Drugs Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Smoking Cessation Drugs Sales by Manufacturers
      • 3.1.1 Smoking Cessation Drugs Sales by Manufacturers 2014-2019
      • 3.1.2 Smoking Cessation Drugs Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Smoking Cessation Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Smoking Cessation Drugs Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Smoking Cessation Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.3 Smoking Cessation Drugs Price by Manufacturers
    • 3.4 Key Manufacturers Smoking Cessation Drugs Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Smoking Cessation Drugs Market
    • 3.6 Key Manufacturers Smoking Cessation Drugs Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 NRTs Products Sales and Revenue (2014-2019)
      • 4.1.2 Nicotine-Free Products Sales and Revenue (2014-2019)
    • 4.2 Global Smoking Cessation Drugs Sales Market Share by Type
    • 4.3 Global Smoking Cessation Drugs Revenue Market Share by Type
    • 4.4 Smoking Cessation Drugs Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Smoking Cessation Drugs Sales by Application

    6 United States

    • 6.1 United States Smoking Cessation Drugs Breakdown Data by Company
    • 6.2 United States Smoking Cessation Drugs Breakdown Data by Type
    • 6.3 United States Smoking Cessation Drugs Breakdown Data by Application

    7 European Union

    • 7.1 European Union Smoking Cessation Drugs Breakdown Data by Company
    • 7.2 European Union Smoking Cessation Drugs Breakdown Data by Type
    • 7.3 European Union Smoking Cessation Drugs Breakdown Data by Application

    8 China

    • 8.1 China Smoking Cessation Drugs Breakdown Data by Company
    • 8.2 China Smoking Cessation Drugs Breakdown Data by Type
    • 8.3 China Smoking Cessation Drugs Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Smoking Cessation Drugs Breakdown Data by Company
    • 9.2 Rest of World Smoking Cessation Drugs Breakdown Data by Type
    • 9.3 Rest of World Smoking Cessation Drugs Breakdown Data by Application
    • 9.4 Rest of World Smoking Cessation Drugs Breakdown Data by Countries
      • 9.4.1 Rest of World Smoking Cessation Drugs Sales by Countries
      • 9.4.2 Rest of World Smoking Cessation Drugs Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 GSK
      • 10.1.1 GSK Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Smoking Cessation Drugs
      • 10.1.4 Smoking Cessation Drugs Product Introduction
      • 10.1.5 GSK Recent Development
    • 10.2 Pfizer
      • 10.2.1 Pfizer Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Smoking Cessation Drugs
      • 10.2.4 Smoking Cessation Drugs Product Introduction
      • 10.2.5 Pfizer Recent Development
    • 10.3 Kimree Technology
      • 10.3.1 Kimree Technology Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Smoking Cessation Drugs
      • 10.3.4 Smoking Cessation Drugs Product Introduction
      • 10.3.5 Kimree Technology Recent Development
    • 10.4 Johnson & Johnson
      • 10.4.1 Johnson & Johnson Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Smoking Cessation Drugs
      • 10.4.4 Smoking Cessation Drugs Product Introduction
      • 10.4.5 Johnson & Johnson Recent Development
    • 10.5 Novartis
      • 10.5.1 Novartis Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Smoking Cessation Drugs
      • 10.5.4 Smoking Cessation Drugs Product Introduction
      • 10.5.5 Novartis Recent Development
    • 10.6 Dr. Reddy's Laboratories
      • 10.6.1 Dr. Reddy's Laboratories Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Smoking Cessation Drugs
      • 10.6.4 Smoking Cessation Drugs Product Introduction
      • 10.6.5 Dr. Reddy's Laboratories Recent Development
    • 10.7 The Harvard Drug Group
      • 10.7.1 The Harvard Drug Group Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Smoking Cessation Drugs
      • 10.7.4 Smoking Cessation Drugs Product Introduction
      • 10.7.5 The Harvard Drug Group Recent Development
    • 10.8 Perrigo Company
      • 10.8.1 Perrigo Company Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Smoking Cessation Drugs
      • 10.8.4 Smoking Cessation Drugs Product Introduction
      • 10.8.5 Perrigo Company Recent Development
    • 10.9 Fontem Ventures
      • 10.9.1 Fontem Ventures Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Smoking Cessation Drugs
      • 10.9.4 Smoking Cessation Drugs Product Introduction
      • 10.9.5 Fontem Ventures Recent Development
    • 10.10 Smoke Away
      • 10.10.1 Smoke Away Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Smoking Cessation Drugs
      • 10.10.4 Smoking Cessation Drugs Product Introduction
      • 10.10.5 Smoke Away Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Smoking Cessation Drugs Sales Channels
      • 11.2.2 Smoking Cessation Drugs Distributors
    • 11.3 Smoking Cessation Drugs Customers

    12 Market Forecast

    • 12.1 Global Smoking Cessation Drugs Sales and Revenue Forecast 2019-2025
    • 12.2 Global Smoking Cessation Drugs Sales Forecast by Type
    • 12.3 Global Smoking Cessation Drugs Sales Forecast by Application
    • 12.4 Smoking Cessation Drugs Forecast by Regions
      • 12.4.1 Global Smoking Cessation Drugs Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Smoking Cessation Drugs Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Smoking Cessation Drugs. Industry analysis & Market Report on Smoking Cessation Drugs is a syndicated market report, published as Global (United States, European Union and China) Smoking Cessation Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Smoking Cessation Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,614.16
      3,921.24
      5,228.32
      3,050.40
      4,575.60
      6,100.80
      501,446.40
      752,169.60
      1,002,892.80
      273,650.40
      410,475.60
      547,300.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report